• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Risks and Benefits of Long-Term Use of Nicotine Replacement Therapy (NRT) Products; Public Workshop

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) is announcing a scientific workshop that will focus on the risks and benefits associated with the long-term use of nicotine replacement therapy (NRT) products.  NRT products facilitate smoking cessation by ameliorating the symptoms of nicotine withdrawal and are available as approved nonprescription and prescription drugs. No currently approved NRT product is intended for use beyond 12 weeks to relieve the acute withdrawal symptoms experienced when quitting smoking.

Date(s):   October 26-27, 2010

Time:       8:30 a.m. to 5:00 p.m.

Location:  Radisson Hotel, Reagan National Airport
                2020 Jefferson Davis Highway
                Arlington, VA 22202

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.